EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
2.6.1.15 | Acidosis |
5551130 |
Effect of chronic alkalosis and acidosis on glutaminase II path in the dog kidney in vivo. |
ongoing research therapeutic application unassigned |
4 1 0 |
2.6.1.15 | Alkalosis |
5551130 |
Effect of chronic alkalosis and acidosis on glutaminase II path in the dog kidney in vivo. |
ongoing research therapeutic application unassigned |
4 1 0 |
2.6.1.15 | Astrocytoma |
13932941 |
[Glutamine transaminase in brain preparations and in cells of a strain of differentiated human astrocytoma.] |
ongoing research unassigned |
4 0 |
2.6.1.15 | Astrocytoma |
14060299 |
GLUTAMINE TRANSAMINASE IN BRAIN TISSUE PREPARATIONS AND IN CELLS OF A HUMAN STRAIN OF DEDIFFERENTIATED ASTROCYTOMA. |
ongoing research unassigned |
4 0 |
2.6.1.15 | Carcinogenesis |
31231915 |
Upregulation of the Glutaminase II Pathway Contributes to Glutamate Production upon Glutaminase 1 Inhibition in Pancreatic Cancer. |
causal interaction therapeutic application unassigned |
4 4 0 |
2.6.1.15 | Carcinoma |
21485 |
[Specificity of glutamine metabolism in pre-tumorous diseases and cancer of the human stomach] |
causal interaction diagnostic usage ongoing research unassigned |
1 2 4 0 |
2.6.1.15 | Gastritis, Atrophic |
21485 |
[Specificity of glutamine metabolism in pre-tumorous diseases and cancer of the human stomach] |
causal interaction diagnostic usage ongoing research unassigned |
1 2 4 0 |
2.6.1.15 | Hepatic Encephalopathy |
30643050 |
[Analysis of prognostic factors and construction of a logistic regression model for patients with drug-induced liver failure]. |
diagnostic usage unassigned |
4 0 |
2.6.1.15 | Hepatorenal Syndrome |
30643050 |
[Analysis of prognostic factors and construction of a logistic regression model for patients with drug-induced liver failure]. |
diagnostic usage unassigned |
4 0 |
2.6.1.15 | Liver Diseases |
30643050 |
[Analysis of prognostic factors and construction of a logistic regression model for patients with drug-induced liver failure]. |
diagnostic usage unassigned |
4 0 |